NCT05168059View on ClinicalTrials.gov

Clevidipine in Neurocritical Patients

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

September 1, 2019

Conditions
High Blood Pressure
Interventions
DRUG

Clevidipine 0.5 MG/ML Intravenous Emulsion

Effectiveness and safety of clevidipine

Trial Locations (1)

48903

Biocruces, Barakaldo

All Listed Sponsors
collaborator

Biocruces Bizkaia Health Research Institute

OTHER_GOV

lead

Hospital de Cruces

OTHER

NCT05168059 - Clevidipine in Neurocritical Patients | Biotech Hunter | Biotech Hunter